Kymera Therapeutics to announce KT-579 Phase 1 healthy volunteer trial results on October 29, 2026
KYMR•Kymera Therapeutics will announce KT-579 Phase 1 healthy volunteer trial results on October 29, 2026.
1. Results announcement
Kymera Therapeutics said it will announce KT-579 Phase 1 healthy volunteer trial results on October 29, 2026.
